tirzepatide co Compounded Online for Diabetes & Weight Loss Tirzepatide (Zepbound, Mounjaro): Weight Loss,

A new study, published in The BMJ, suggests that adults with Type 2 diabetes taking GLP-1 receptor agonists a class of drugs that mimics a natural gut hormone to regulate blood sugar, decrease appetite, and slow digestion may have a slightly higher risk of developing hair loss, or alopecia, compared with those using other commonly prescribed diabetes medications

Others report no noticeable effects despite weeks of consistent use

The consult helps determine fit and outline next steps before any commitment

Common (Both Medications) Nausea Most common side effect

There also appeared to be an overlap in predicted exposure between the two weight groups at the same dose